Story thread · 2 reports / 2 sources
AbbVie’s zumilokibart meets phase 2 atopic dermatitis endpoint
investing.com · 4h · first report
The coverage
- AbbVie reports positive phase 2 data for Zumilokibart in atopic dermatitis
seekingalpha.com · 3h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.